Position in CRIS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$73,825
-$127,882 QoQ
Shares Held
7,099
-61.3% QoQ
Ownership
0.340%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 36 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRIS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,606,887 across 312 Biotechnology names. CRIS ranks #281 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in CRIS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,825 | 141,972 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $201,707 | 366,740 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $238,507 | 240,917 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $291,351 | 175,513 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $233,095 | 100,472 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $203,431 | 96,872 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $287,860 | 94,072 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $505,431 | 93,772 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $642,886 | 93,172 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $995,289 | 91,563 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,149,578 | 90,163 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $563,860 | 85,563 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,395 | 1,681,235 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $970 | 1,627,400 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $841 | 1,528,800 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,448,000 | 2,068,700 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,355,000 | 2,392,035 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,137,000 | 1,318,200 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,080,000 | 437,000 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $6,917,000 | 611,004 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $13,089,000 | 1,598,224 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,807,000 | 1,544,404 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $2,667,000 | 2,203,899 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $1,135,000 | 1,612,504 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||